U.S. General Merchandise and Department Stores Stock News

IQVIA Holdings (NYSE:IQV) executive Dr. Cynthia Verst testified before a U.S. House congressional subcommittee on modernizing early clinical development in the United States. The testimony focused on recommendations to improve regulatory engagement, research infrastructure, and the path from discovery to first in human studies. IQVIA Holdings, through its contract research and data analytics operations, sits close to the early stages of drug and device development. Dr. Verst’s appearance in...

Recently, Curbline Properties (CURB) received a Momentum Style Score of B and a Zacks Rank of #2, supported by analysts raising earnings estimates for the current and next fiscal years. This combination of upgraded projections and momentum ratings points to strengthening analyst confidence in Curbline’s operating trajectory relative to its retail REIT peers. Next, we’ll examine how these earnings estimate revisions could influence Curbline’s acquisition-led growth narrative and expectations...

H2O America stock has delivered a 34.6% return over the past year, yet the valuation checks currently point to the shares trading at a premium rather than offering clear value. Over the last 12 months, H2O America has returned 34.6%. This puts recent share price enthusiasm in focus against what the fundamentals suggest investors are paying. The long term investment case can be supported if H2O America continues to convert earnings into reliable dividends, while any pressure on cash flows or...

Pitney Bowes recently highlighted its higher-than-industry dividend yield, lifting its annualized payout to US$0.10 per share, with a 33.3% increase from last year supported by a low payout ratio and an improving earnings outlook. At the same time, the company’s pivot toward higher-growth, technology-enabled logistics and SaaS shipping services is adding weight to expectations that its evolving business mix can underpin both income and operational resilience. We’ll now examine how Pitney...

After roughly doubling over the past five years, ePlus stock now sits at a level where the Discounted Cash Flow (DCF) intrinsic value estimate suggests the shares trade at a premium. Broader valuation checks point to a more mixed picture rather than a clear warning sign. ePlus has returned about 102% over the past five years, so the stock is no longer an obvious bargain based purely on its recent track record. Strong recent momentum in the IT distribution and solutions business can support...

RPC (RES) amended and restated its revolving credit agreement, extending the facility to 2031 and removing a SOFR pricing adjustment, a move that directly affects liquidity access and borrowing costs. See our latest analysis for RPC. At a share price of $5.91, RPC has seen a 1-day share price return of 1.20% and a 7-day share price return of 4.60%. Over longer periods, the 30 day share price return is down 11.13% and the 90 day share price return is down 9.49%. The 1 year total shareholder...

Nasdaq stock has delivered a strong 88.3% return over the past three years. However, both the Excess Returns intrinsic value estimate and the market multiple checks currently point to the shares trading at a premium rather than as a clear bargain. Nasdaq's 88.3% gain over three years highlights how much expectations have risen. This raises the bar for what counts as good value today. Growing interest from international companies seeking U.S. listings can support Nasdaq's potential earnings...

Bank of N.T. Butterfield & Son (NYSE:NTB) has drawn attention after recent trading left the stock at a last close of US$61.37. This has invited investors to weigh its current valuation and fundamental profile. See our latest analysis for Bank of N.T. Butterfield & Son. For context, Bank of N.T. Butterfield & Son's share price has eased 1.71% over the last day but is still up 5.70% over 30 days and 23.48% year to date. Its 1 year total shareholder return of 39.58% and 5 year total shareholder...

Allstate stock has delivered a strong 140.7% return over the past three years, yet current valuation checks still lean toward the shares looking inexpensive relative to underlying fundamentals, even as investors weigh recent catastrophe losses and legal headlines. The 140.7% three year return puts Allstate among the stronger performers in the insurance sector, which raises the question of how much good news may already be reflected in the price. On the one hand, investors may see the...

Albany International partnership with A&P Technology: why it matters for investors Albany International (AIN) is in focus after its Albany Engineered Composites segment agreed with A&P Technology to develop braided composite manufacturing solutions for aerospace and defense, targeting current and next generation aircraft platforms. See our latest analysis for Albany International. The new aerospace and defense partnership comes as Albany International’s share price, now at $74.54, shows...

Anyone interested in FB Financial Corporation ( NYSE:FBK ) should probably be aware that the Chief Accounting Officer...

We can readily understand why investors are attracted to unprofitable companies. By way of example, Camp4 Therapeutics...

In recent days, Hub Group has drawn attention as transportation and logistics stocks rallied alongside improving freight indicators such as the Cass Freight Shipments Index, even as the company faces multiple securities class actions over alleged accounting misstatements and internal control weaknesses. This combination of stronger industry freight data and legal scrutiny over a disclosed US$77 million accounting error presents investors with a complex mix of improving sector sentiment and...

RenaissanceRe Holdings stock has delivered a 124.7% return over the past 5 years, and the current valuation checks indicate that the shares may still be inexpensive relative to the company’s fundamentals. RenaissanceRe Holdings' 124.7% 5-year return indicates that long-term holders have already seen solid gains, so any further upside may depend on whether current expectations for the business remain intact. For a reinsurer like RenaissanceRe Holdings, the outlook for underwriting...

We wouldn't blame Incyte Corporation ( NASDAQ:INCY ) shareholders if they were a little worried about the fact that...

Ameren (AEE) has caught investors’ attention after outperforming the broader Utilities sector, with an estimated year to date return near 11.5% compared with about 6.5% for peers. See our latest analysis for Ameren. Over the past year, Ameren’s share price performance has been steadier than spectacular, with the stock at about $111.55 after a modest 1-month share price gain of 2.41% and a stronger 1-year total shareholder return of 16.24%. This suggests that dividends have played a meaningful...

Viewing insider transactions for Candel Therapeutics, Inc.'s ( NASDAQ:CADL ) over the last year, we see that insiders...

Earlier this week, Jefferies analysts said Take-Two Interactive’s upcoming fiscal first-quarter update is expected to be broadly in line, but investors are primarily watching for any management commentary on the timing and scope of Grand Theft Auto VI. The key insight is that expectations and uncertainty around GTA VI, especially its online component, are now more influential for sentiment than near-term quarterly performance. We’ll now examine how this heightened focus on GTA VI’s launch...

The new 25% US tariff on a broad range of Brazilian imports puts fresh attention on US Domestic Manufacturing stocks that could see shifts in demand, costs, or competitive positioning as supply chains adjust. With key Brazilian exports like coffee, beef, orange juice, and aircraft parts exempt, the impact is focused on other areas where domestic producers might gain or face new pressures. This article walks through 3 stocks from the US Domestic Manufacturing screener that appear positively...

Looking at Anteris Technologies Global Corp.'s ( NASDAQ:AVR ) insider transactions over the last year, we can see that...

Some Tower Semiconductor Ltd. ( NASDAQ:TSEM ) shareholders may be a little concerned to see that the CEO & Director...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Immunome (IMNM) is in focus after the FDA accepted its New Drug Application for varegacestat, an oral therapy for adults with desmoid tumors, supported by positive Phase 3 RINGSIDE trial data. See our latest analysis for Immunome. The FDA’s acceptance of Immunome’s NDA comes after a mixed period for the stock, with a 20.45% 1 month share price return but a 9.38% decline over three months. The 1 year total shareholder return of 110.96% points to strong longer term momentum. If this kind of...

UroGen Pharma (URGN) is back in focus after the FDA cleared its Investigational New Drug application for UGN-501, allowing the company to move ahead with a Phase 1 bladder cancer study. See our latest analysis for UroGen Pharma. Against this backdrop, UroGen Pharma’s share price has climbed strongly, with a 30-day share price return of 22.62% and a 90-day share price return of 78.48%, while the 1-year total shareholder return of 163.46% points to powerful momentum rather than a short-lived...